In vivo therapeutic efficacy of chloroquine alone or in combination with primaquine against vivax malaria in kolkata, west bengal, india, and polymorphism in pvmdr1 and pvcrt-o genes

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 3, 2013, Pages 1246-1251

  Ganguly, Swagata ^a   Saha, Pabitra ^a   Guha, Subhasish K ^a   Das, Sonali ^a   Bera, Dilip K ^a   Biswas, Asit ^b   Kundu, Pratip K ^a   Saha, Bibhuti ^a   Ray, Krishnangshu ^a   Maji, Ardhendu K ^a  

^a CALCUTTA SCHOOL OF TROPICAL MEDICINE   (India)

^b Government of West Bengal   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; CHLOROQUINE PLUS PRIMAQUINE; HEMOGLOBIN; PROTEIN; PVCRT O PROTEIN; PVMDR1 PROTEIN; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ARTICLE; BODY TEMPERATURE; CHILD; CONTROLLED STUDY; DIARRHEA; DNA POLYMORPHISM; DNA SEQUENCE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FEVER; FOLLOW UP; GENE MUTATION; HAPLOTYPE; HEADACHE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; NAUSEA; NUCLEOTIDE SEQUENCE; PLASMODIUM VIVAX MALARIA; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; TREATMENT RESPONSE; VOMITING;

ADOLESCENT; ADULT; AGED; ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; CHLOROQUINE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INDIA; MALARIA, VIVAX; MALE; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; MUTATION; PLASMODIUM VIVAX; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PRIMAQUINE; PROTOZOAN PROTEINS; TREATMENT OUTCOME;

EID: 84874087633     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02050-12     Document Type: Article

References (36)

1. Mendis K, Sina BJ, Marchesini P, Carter R. 2001. The neglected burden of Plasmodium vivax malaria. Am. J. Trop. Med. Hyg. 64:97-106.
2. Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, Anstey NM. 2007. Vivax malaria: neglected and not benign. Am. J. Trop. Med. Hyg. 77:79 - 87.
3. Hay SI, Guerra CA, Tatem AJ, Noor AM, Snow RW. 2004. The global distribution and population at risk of malaria: past, present, and future. Lancet Infect Dis. 4:327-336.
4. UK Aid, Department for International Development. 31 December 2010. Malaria: burden and interventions: evidence overview. A working paper, version 1.0. Department for International Development, London, United Kingdom. http://www.dfid.gov.uk/Documents/prd/malaria-evidence-paper.pdf.
5. Guerra CA, Howes RE, Patil AP, Gething PW, Van Boeckel TP, Temperley WH, Kabaria CW, Tatem AJ, Manh BH, Elyazar IRF, Baird JK, Snow RW, Hay SI. 2010. The international limits and population at risk of Plasmodium vivax transmission in 2009. PLoS Negl. Trop. Dis. 4:e774. doi:10.1371/journal.pntd.0000774.
6. Baird JK. 2008. Real-world therapies and the problem of vivax malaria. N. Engl. J. Med. 359:2601-2603.
7. Baird JK. 2007. Neglect of Plasmodium vivax malaria. Trends Parasitol. 23:533-539.
8. Kochar DK, Das A, Kochar SK, Saxena V, Sirohi P, Garg S, Kochar A, Khatri MP, Gupta V. 2009. Severe Plasmodium vivax malaria: a report on serial cases from Bikaner in northwestern India. Am. J. Trop. Med. Hyg. 80:194 -198.
9. Rieckmann KH, Davis DR, Hutton DC. 1989. Plasmodium vivax resistance to chloroquine? Lancet 1183-1184.
10. Baird JK, Basri H, Subianto B, Fryauff DJ, McElroy PD, Leksana B, Richie TL, Masbar S, Wignall FS, Hoffman SL. 1995. Treatment of chloroquine resistant Plasmodium vivax with chloroquine and primaquine or halofantrine. J. Infect. Dis. 171:1678 -1682.
11. Baird JK, Leksana B, Masbar S, Fryauff DJ, Sutanihardja MA, Suradi Wignall FS, Hoffman SL. 1997. Diagnosis of resistance to chloroquine by Plasmodium vivax: timing of recurrence and whole blood chloroquine levels. Am. J. Trop. Med. Hyg. 56:621- 626.
12. Baird JK, Wiady I, Fryauff DJ, Sutanihardja MA, Leksana B, Widjaya H, Kysdarmanto, Subianto B. 1997. In vivo resistance to chloroquine by Plasmodium vivax and Plasmodium falciparum at Nabire, Irian Jaya, Indonesia. Am. J. Trop. Med. Hyg. 56:627- 631.
13. Ratcliff A, Siswantoro H, Kenangelem E, Wuwung M, Brockman A, Edstein MD, Laihad F, Ebsworth EP, Anstey NM, Titra E, Price RN. 2007. Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine-pyrimethamine in southern Papua, Indonesia. Trans. R. Soc. Trop. Med. Hyg. 101:351-359.
14. Sutanto I, Suprijanto S, Nurhayati, Manoempil P, Baird JK. 2009. Resistance to chloroquine by Plasmodium vivax at Alor in the Lesser Sundas Archipelago in eastern Indonesia. Am. J. Trop. Med. Hyg. 81:338 -342.
15. Baird JK. 2009. Resistance to therapies for infection by Plasmodium vivax. Clin. Microbiol. Rev. 22:508 -534.
16. Barnadas C, Ratsimbasoa A, Tichit M, Bouchier C, Jahevitra M, Picot S, Ménard D. 2008. Plasmodium vivax resistance to chloroquine in Madagascar: clinical efficacy and polymorphisms in pvmdr1 and pvcrt-o genes. Antimicrob. Agents Chemother. 52:4233- 4240.
17. Teka H, Petros B, Yamuah L, Tesfaye G, Elhassan I, Muchohi S, Kokwaro G, Aseffa A, Engers H. 2008. Chloroquine-resistant Plasmodium vivax malaria in Debre Zeit, Ethiopia. Malar. J. 7:220. doi:10.1186/1475-2875-7-220.
18. Dua VK, Kar PK, Sharma VP. 1996. Chloroquine resistant Plasmodium vivax malaria in India. Trop. Med. Int. Health 1:816-819.
19. Kshirsagar NA, Gogtay NJ, Rojgor D, Dalvi SS, Wakde M. 2000. An unusual case of multidrug-resistant Plasmodium vivax malaria in Mumbai (Bombay), India. Ann. Trop. Med. Parasitol. 94:189 -190.
20. Srivastava HC, Yadav RS, Joshi H, Valecha N, Mallick PK, Prajapati SK, Dash AP. 2008. Therapeutic responses of Plasmodium vivax and P. falciparum to chloroquine, in an area of western India where P. vivax predominates. Ann. Trop. Med. Parasitol. 102:471- 480.
21. Brega S, Meslin B, de Monbrison F, Severini C, Gradoni L, Udomsangpetch R, Sutanto I, Peyron F, Picot S. 2005. Identification of the Plasmodium vivax mdr-like gene (pvmdr1) and analysis of single-nucleotide polymorphisms among isolates from different areas of endemicity. J. Infect. Dis. 191:272-277.
22. Sá JM, Yamamoto MM, Fernandez-Becerra C, de Azevedo MF, Papakrivos J, Naudé B, Wellems TE, del Portillo HA. 2006. Expression and function of pvcrt-o, a Plasmodium vivax ortholog of pfcrt, in Plasmodium falciparum and Dictyostelium discoideum. Mol. Biochem. Parasitol. 150: 219-228.
23. World Health Organization. 2009. Methods for surveillance of antimalarial drug efficacy. WHO, Geneva, Switzerland.
24. Tham JM, Lee SH, Tam TMC, Ting RCY, Kara UAK. 1999. Detection and species determination of malaria parasites by PCR: comparison with microscopy and with ParaSight-F and ICT malaria Pf tests in a clinical environment. J. Clin. Microbiol. 37:1269 -1273.
25. Suwanarusk R, Russell B, Chavchich M, Chalfein F, Kenangalem E, Kosaisavee V, Prasetyorini B, Piera KA, Barends M, Brockman A, Lek-Uthai U, Anstey NM, Tjitra E, Nosten F, Cheng Q, Price RN. 2007. Chloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphisms. PLoS One 2:e1089. doi:10 .1371/journal.pone.0001089.
26. World Health Organization. 2007. Recommended genotyping procedures (RGPs) to identify parasite populations. WHO, Amsterdam, The Netherlands.
27. Bruce MC, Galinski MR, Barnwell JW, Snounou G, Day KP. 1999. Polymorphism at the merozoite surface protein-3- locus of Plasmodium vivax: global and local diversity. Am. J. Trop. Med. Hyg. 61:518 -525.
28. Imwong M, Pukrittayakamee S, Grüner AC, Rénia L, Letourneur F, Looareesuwan S, White NJ, Snounou G. 2005. Practical PCR genotyping protocols for Plasmodium vivax using Pvcs and Pvmsp1. Malar. J. 4:20.
29. Nandy A, Addy M, Maji AK, Bandyopadhyay AK. 2003. Monitoring the chloroquine sensitivity of Plasmodium vivax from Calcutta and Orissa, India. Ann. Trop. Med. Parasitol. 97:215-220.
30. Kim JR, Nandy A, Maji AK, Addy M, Dondorp AM, Nicholas PJD, Pukrittayakamee S, White NJ, Imwong M. 2012. Genotyping of Plasmodium vivax reveals both short and long latency relapse patterns in Kolkata. PLoS One 7:e39645. doi:10.1371/journal.pone.0039645.
31. Saha P, Mullick S, Guha SK, Das S, Ganguly S, Chatterjee M, Biswas S, Bera DK, Chakravorty A, Mukherjee B, Das M, Kundu PK, Ray K, Maji AK. 2011. Distribution of pfcrt haplotypes and in-vivo efficacy of chloroquine in treatment of uncomplicated P. falciparum malaria before deploy-ment of artemisinin combination therapies in urban population of Kolkata, India. Int. J. Parasitol. Res. 3:39-47.
32. Leslie T, Briceño M, Mayan I, Mohammed N, Klinkenberg E, Sibley CH, Whitty CJM, Rowland M. 2010. The impact of phenotypic and genotypic G6PD deficiency on risk of Plasmodium vivax infection: a casecontrol study amongst Afghan refugees in Pakistan. PLoS Med. 7:e1000283. doi:10.1371/journal.pmed. 1000283.
33. Louicharoen C, Etienne Patin E, Paul R, Nuchprayoon I, Witoonpanich B, Peerapittayamongkol C, Casademont I, Sura T, Laird NM, Singhasivanon P, Quintana-Murci L, Sakuntabhai A. 2009. Positively selected G6PD-Mahidol mutation reduces Plasmodium vivax density in Southeast Asians. Science 326:1546 -1549.
34. Nomura T, Carlton JM, Baird JK, del Portillo HA, Fryauff DJ, Rathore D, Fidock DA, Su XZ, Collins WE, McCutchan TF, Wootton JC, Wellems TE. 2001. Evidence for different mechanisms of chloroquine resistance in 2 Plasmodium species that cause human malaria. J. Infect Dis. 183:1653-1661.
35. Sá JM, Nomura T, Neves J, Baird JK, Wellems TE, Del Portillo HA. 2005. Plasmodium vivax: allele variants of the mdr1 gene do not associate with chloroquine resistance among isolates from Brazil, Papua, and monkey- adapted strains. Exp. Parasitol. 109:256 -259.
36. Marfurt J, Müeller I, Sie A, Maku P, Goroti M, Reeder JC, Beck HP, Genton B. 2007. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea. Am. J. Trop. Med. Hyg. 77:947- 954.